Version 2.77

Description

Everolimus is a kinase inhibitor that is used to treat a number of cancers and to prevent rejection of organ transplants. It is an mTOR inhibitor, and has been effective against renal cell carcinoma, pancreatic neuroendocrine tumors, and advanced kidney tumors, all of which have been unsuccessfully treated with other medications. [MedlinePlus:druginfo/meds/a609032] [NCI:about-cancer/treatment/drugs/fda-everolimus] PMCID: PMC4385860 Source: Regenstrief LOINC

Basic Part Properties

Part Display Name
Everolimus
Part Type
Component (Describes the core component or analyte measured)
Created On
2007-10-01
Construct for LOINC Short Name
Everolimus

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP65523-0
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP65523-0

Language Variants Get Info

Tag Language Translation
et-EE Estonian (Estonia) Everoliimus
es-ES Spanish (Spain) Everolimus
it-IT Italian (Italy) Everolimus
tr-TR Turkish (Turkey) Everolimus
ru-RU Russian (Russian Federation) Эверолимус
nl-NL Dutch (Netherlands) everolimus
fr-BE French (Belgium) Everolimus
zh-CN Chinese (China) 依维莫司
Synonyms: 40-O-(2-羟乙基)-西罗莫司;40-O-(2-羟乙基)-雷帕霉素;Everolimus;依维菌素;西罗莫司(sirolimus)的衍生物;雷帕霉素(rapamycin)的衍生物